Medical Newswire

Medical Newswire!

Medicine, Healthcare, Medical Research, Hospitals, Management
Press release distribution service
Home | Medical-Newswire.Com:

'EMT Paramedic Training' In California Information is Now Available for Prospective Students to See.

(EMAILWIRE.COM, April 11, 2012 ) Clarkston, Washington -- According to the United States Department of Labor, Employment of Emergency Medical Technicians (EMTs) and EMT paramedics is expected to grow by 19 percent between 2006 and 2016, which is faster than the average for all occupations. Regardless of the current economic challenges for jobs and employment, pursing EMT and EMT paramedic certification is a worthy career path.

California has one of the largest EMT/EMS services in the entire country and the state is continually hiring certified EMT personnel. EMT training and EMT paramedic training, licensing, and certification in the state of California are governed by the Emergency Medical Services Authority or EMSA. This state bureau has the responsibility of managing the entire EMS system for the state of California.

Both EMTs and EMT paramedics must complete a CA EMT training program that is state accredited in order to be certified. California EMT training alone is not sufficient; it requires a state accredited program or courses. The state of California and the EMSA also require the individual who has completed EMT training to pass the National Registry of Emergency Medical Technicians (NREMT) exam and recognizes the exam certification if taken in other states.
California EMT training applicants who wish to take the EMT certification test are first required to have 110 hours of EMT training instructional study, and another 10 hours of medical training studies. Paramedic training in California requires a minimum of 1,090 hours for training.

It is becoming increasingly difficult for emergency medical services to recruit and retain unpaid volunteers because of the amount of EMT training and EMT paramedic training, and the large time commitment these positions require. Not to mention liability. As a result, more paid EMTs and paramedics are needed. Furthermore, as a large segment of the population—aging members of the baby boom generation—becomes more likely to have medical emergencies, demand will increase for EMTs and paramedics. There will still be demand for part-time, volunteer EMTs and paramedics in rural areas and smaller metropolitan areas.

Job prospects for EMTs and paramedics should be very favorable and job opportunities should be best in private ambulance services. Competition will be greater for jobs in local government, including fire, police, and independent third-service rescue squad departments, which tend to have better salaries and benefits. EMTs and paramedics who have advanced EMT training education and paramedic training, such as Paramedic level certification, should enjoy the most favorable job prospects, as employees and patients demand higher levels of care before arriving at the hospital.

About EMT Paramedic Training:

Our website, EMT Paramedic Training, offers current updates for EMT training, paramedic training, and EMT paramedic schools and programs. Recent posts include details on California paramedic colleges, as well as EMT training programs from around the United States and internationally.

JR Consumer Resources Inc.
Linda Phillips Dahl
(208) - 746 - 7971
paramedicschools@cableone.netlvassit@cableone.net

Source: EmailWire.com


Medical Resources
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Healthcare resource center today to browse our selection of 600+ complimentary Healthcare magazines, white papers, webinars, podcasts, and more. Get popular titles including:

Eyecare Business
Medical Laboratory Observer
FierceHealthcare

No credit cards, coupons, or promo codes required. Try it today!

Medical Sponsors

Health News
Health News Headlines - Yahoo News
Health News Headlines - Yahoo News
Get the latest health news headlines from Yahoo News. Find breaking health news, including analysis and opinion on top health stories.

Commentary: Update of Toxic Substances Control Act a worthy step that's long ...
27 May 2016 at 2:00am
Upgrade of Toxic Substances Control Act long overdue


AstraZeneca potassium drug delayed by manufacturing snag
27 May 2016 at 1:55am

AstraZeneca said on Friday U.S. regulators would not approve its new drug for high potassium levels at present due to a manufacturing issue, dealing a blow to a product acquired when it bought ZS Pharma for $2.7 billion last year. Analysts said the drug's launch would now likely be delayed until 2017 after the British drugmaker said the Food and Drug Administration (FDA) had issued a so-called complete response letter (CRL) for ZS-9, or sodium zirconium cyclosilicate. "The CRL refers to observations arising from a pre-approval manufacturing inspection," AstraZeneca said.



G7 told to act on antibiotics as dreaded superbug hits U.S.
27 May 2016 at 1:37am

By Kylie MacLellan and Ben Hirschler ISE-SHIMA, Japan/LONDON (Reuters) - Britain told the G7 industrial powers on Friday to do more to fight killer superbugs as the United States reported the first case in the country of a patient with bacteria resistant to a last-resort antibiotic. U.S. scientists said the infection in a 49-year-old Pennsylvania woman "heralds the emergence of truly pan-drug resistant bacteria" because it could not be controlled even by colistin, an antibiotic reserved for "nightmare" bugs. In Japan, British Prime Minister David Cameron said leading countries needed to tackle resistance by reducing the use of antibiotics and rewarding drug companies for developing new medicines.



Roche boosted by trial success with blood cancer drug
27 May 2016 at 12:33am

Roche got a big boost on Friday when a clinical trial testing its new blood cancer drug Gazyva proved successful, lifting prospects for a new medicine that will be pivotal as the Swiss company fights the threat of biosimilar competition. Roche said Gazyva proved significantly better than its older drug Rituxan at delaying the progression of disease in people with previously untreated follicular lymphoma. Clinical trials with the new drug are important in deciding how well the Swiss drugmaker is placed to fend off cheaper competition from so-called biosimilar copies of Rituxan, which are likely to hit the market in the next couple of years.


British PM Cameron says happy to meet Trump but no dates fixed
26 May 2016 at 11:54pm
ISE-SHIMA, Japan (Reuters) - Prime Minister David Cameron said on Friday that no dates had been fixed for a potential visit by Donald Trump to Britain but that he would be happy to meet the presumptive Republican presidential nominee if he did visit. "Often these candidates chose to come through various European countries in the run up to the U.S. elections. No dates are fixed but I am always happy to meet people on that basis," Cameron told reporters at the G7.

Cameron says happy to meet Trump but no dates fixed
26 May 2016 at 11:49pm
ISE-SHIMA, Japan (Reuters) - Prime Minister David Cameron said on Friday that no dates had been fixed for a potential visit by Donald Trump to Britain but that he would be happy to meet the presumptive Republican presidential nominee if he did visit. "Often these candidates chose to come through various European countries in the run up to the U.S. elections. No dates are fixed but I am always happy to meet people on that basis," Cameron told reporters at the G7.

Factbox: Hiroshima survivor - Obama apology would ease my suffering
26 May 2016 at 11:45pm
By Minami Funakoshi HIROSHIMA (Reuters) - Barack Obama, the first sitting U.S. president to visit Hiroshima, will lay a wreath on Friday at the site of the world's first atomic bombing, which killed thousands instantly. Following are comments from people in Hiroshima, which was devastated on Aug. 6, 1945. "If Obama apologized, I could die and meet my parents in heaven in peace.


Valeant rejected joint takeover bid from Takeda, TPG in spring: source
26 May 2016 at 8:32pm

Valeant Pharmaceuticals International Inc received a joint takeover offer from Japan's Takeda Pharmaceutical Co Ltd and TPG Capital Management LP [TPG.UL] this spring that the Canadian drugmaker rejected, according to a source familiar with the matter. The offer was made a few weeks before Joseph Papa took over as Valeant's new chief executive in April last week, the source told Reuters. Takeda and private equity firm TPG were ready to offer a substantial premium to Valeant, whose stock had fallen about 65 percent this year up to the close of trade on April 22 as the drugmaker was not just seeking a new head but was also hit by an accounting scandal, the source added.



China regulator to launch drug pricing probe in June
26 May 2016 at 7:44pm

China will carry out wide-ranging pricing inspections on drug firms, hospitals and procurement bodies from June 1, the country's top watchdog said on Friday, extending a tough cost-cutting campaign to reduce the price of healthcare. The National Development and Reform Commission (NDRC) said in a statement it would carry out the probes from June 1 until the end of October, checking the "pricing behavior" of drug firms and related institutions. Local media reported earlier this month that China was planning to launch "large-scale and systematic" anti-trust investigation into foreign and local drug firms.


The Color Purple: Biological, Sorority, and Lupy Sisters
26 May 2016 at 6:27pm
"I think it pisses God off if you walk by the color purple in a field somewhere and don't notice it." -Shug Avery in the Color PurpleIt's likely that Alice Walker wasn't thinking about Takisha Mundy and Amy Meachum when she sat down to write her award winning novel, "The Color Purple." Takisha was just beginning elementary school while Amy...

Theranos sued over blood tests, in proposed class action
26 May 2016 at 5:47pm
(Reuters) - Blood-testing company Theranos Inc was sued on Thursday, accused of endangering customer health through "massive failures" that misrepresented the accuracy and quality of its blood tests, according to court papers. The proposed class action was brought in the U.S. District Court for the Northern District of California by the law firm Hagens Berman Sobol Shapiro LLP. It estimated that thousands of consumers could be eligible to join the lawsuit, citing Theranos? claims that it had performed more than 6 million tests.


U.S. sees first case of bacteria resistant to all antibiotics
26 May 2016 at 5:35pm

U.S. health officials on Thursday reported the first case in the country of a patient with an infection resistant to all known antibiotics, and expressed grave concern that the superbug could pose serious danger for routine infections if it spreads. "We risk being in a post-antibiotic world," said Thomas Frieden, director of the U.S. Centers for Disease Control and Prevention, referring to the urinary tract infection of a 49-year-old Pennsylvania woman who had not travelled within the prior five months. Frieden, speaking at a National Press Club luncheon in Washington, D.C., said the infection was not controlled even by colistin, an antibiotic that is reserved for use against "nightmare bacteria." The infection was reported Thursday in a study appearing in Antimicrobial Agents and Chemotherapy, a publication of the American Society for Microbiology.


At G7, Britain presses for global reward system for new antibiotics
26 May 2016 at 4:06pm
By Kylie MacLellan ISE-SHIMA, Japan (Reuters) - Britain is pushing for a global plan to reward drugs companies for developing new antibiotics, while also pledging to cut antibiotic use in England. Former Goldman Sachs chief economist Jim O'Neill, who led the review, said a reward of between $1 billion and $1.5 billion should be paid for any successful new antimicrobial medicine brought to market. British Prime Minister David Cameron will say at the G7 meeting in Japan on Friday that Britain will work with global finance and health experts to develop such as system to bring the new antibiotics to market and make them available to all who need them.


Report: 1st US case of germ resistant to last resort drug
26 May 2016 at 4:03pm

NEW YORK (AP) ? For the first time, a U.S. patient has been infected with bacteria resistant to an antibiotic used as a last resort treatment, scientists said Thursday.



Trump, Sanders explore an unconventional presidential debate
26 May 2016 at 3:15pm

By Emily Stephenson BISMARCK, N.D. (Reuters) - Republican Donald Trump and Democrat Bernie Sanders on Thursday explored staging an unconventional U.S. presidential debate that would sideline Democratic front-runner Hillary Clinton but create a high-ratings television spectacle. The two men - a billionaire and a democratic socialist - expressed interest in a one-on-one encounter in California even though Republican and Democratic presidential candidates traditionally do not debate each other until the parties have selected their nominees. "I'd love to debate Bernie," Trump told reporters in North Dakota, after he secured enough delegates to clinch the Republican presidential nomination.


Pharmanewswire.com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © GroupWeb Media LLC. All Rights Reserved.

For unlimited press release distribution for $99 per month, call (281) 645-4086 or start posting your press releases online at EmailWire.com. CityRegions.Com is part of GropWeb Network, online properties of GroupWeb Media LLC. Copyright © 2012 GroupWeb Media LLC. All Rights Reserved.


GroupWeb Media Network
AfricaNewswire.Net | AppleNews247.Com | AsiaNewsWire.Net | Aviation-NewsWire | Energy Industry | EstateNewsWire | Entertainment-NewsWire.com | Food Beverage News | Glamour NewsWire | Health NewsWire | Hosting NewsWire | i-Auto NewsWire | i-Business News | EuropeNewsWire.Net | iCameroon.com | i-Canada-News.Com | i-SoftwareNews.com | iT-NewsWire.Com
| InvestorsNewsDesk.Com | i-TravelNewsWire.Com | LegalLaw247.com | Medical-NewsWire.com | MiningNewsWire.net | MoneyNewsWire.Net | Movie-Stars-News.Com | PayDayNews247.Com | PharmaNewsWire.Com | Publishing-NewsWire.Com | Shopping-NewsWire.com | Telecom-NewsWire.Net | Transportation-News.Com | USGovernment-News.Com | WebPosters.Net | Wireless-NewsWire.Com |
Medical-Newswire.com - Medicl Newswire and Press Release service of GroupWeb Media LLC